Sarah Timsit

Sarah Timsit

Auto-generated profile, based on publicly available information

Sarah Timsit

Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bichat-Claude Bernard, Laboratoire de Bactériologie

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2023 in Infectious Diseases Now
Verified
Journal Article
Closed access
STSarah Timsit
Sarah Timsit
LALaurence Armand-Lefèvre
Laurence Armand-Lefèvre
JGJérôme Le Goff
Jérôme Le Goff
MSMaud Salmona
Maud Salmona

18 May 2024 in Pathology
Verified
Journal Article
Closed access
SGSimon Garinet
Simon Garinet
ALAudrey Lupo
Audrey Lupo
TDThomas Denize
Thomas Denize
RLRomain Loyaux
Romain Loyaux
STSarah Timsit
Sarah Timsit
HBHélène Blons
Hélène Blons

25 April 2025 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
AAAurelien AUBRY
Aurelien AUBRY
MNMarie-Laure Nere
Marie-Laure Nere
STSarah Timsit
Sarah Timsit
CCCharlotte Calvo
Charlotte Calvo
JDJean-Hugues Dalle
Jean-Hugues Dalle
MSMaud Salmona
Maud Salmona
Background: The modes of transmission of BK polyomavirus (BKPyV) remain incompletely understood. BKPyV infections can lead to hemorrhagic cystitis after hematopoietic stem cell transplantation (HSCT). Hospitalization in a pediatric hematology unit may represent initial exposure to BKPyV due to the high rate of viral shedding among hematology patients. This study explores the potential for nosocomial transmission of BKPyV within a hematology department. Methods: Epidemiologic investigation and BKPyV genome phylogenetic analyses were conducted among individuals with BKPyV DNAuria and/or DNAemia over a 3-year period in a pediatric hematology unit. Results: From November 2019 to December 2022, BKPyV DNA was detected in the urine or plasma of 34 of 173 children following HSCT. An unusually high prevalence of genotype Ia BKPyV was observed in 2021, suggesting possible patient-to-patient transmission. However, despite closely related sequences, they clustered with several GenBank entries, complicating phylogenetic linkage determination. Genetic signature analysis also did not link these sequences to specific patient clinical profiles. Discussion: This study highlights the complexity of establishing nosocomial transmission of BKPyV, even with viral sequence analyses. Future prospective studies should include noncoding control region analysis, serological data, and environmental factors to enhance understanding of BKPyV transmission routes.

22 May 2025 in Journal of Medical Virology
Verified
Journal Article
Open access
STSarah Timsit
Sarah Timsit
GMGuillaume Mellon
Guillaume Mellon
NFNathalie Forgeard
Nathalie Forgeard
SMSéverine Mercier‐Delarue
Séverine Mercier‐Delarue
NMNadia Mahjoub
Nadia Mahjoub
JLJérôme Legoff
Jérôme Legoff
Human parainfluenza virus type 3 (HPIV‐3) can be responsible for mild to severe respiratory infections and hospital epidemics. We investigated an outbreak in a hematology unit. Respiratory viruses were screened using multiplex PCR. HPIV‐3 quantification and whole‐genome sequencing were performed on HPIV‐3 positive respiratory samples. Clinical characteristics, infection progression, incidence rates of respiratory viruses within the hospital and detection of respiratory viruses were documented, along with the reinforcement of infection prevention and control (IPC) measures implemented. Between November 2022, and January 2023, HPIV‐3 was identified in 20 of 113 hematology patients (17.7%), of whom 80% had multiple myeloma. A majority of HPIV‐3‐positive patients developed pneumonia (60%), and mortality was notably higher (35%) compared to patients who were negative (3%, p < 0.0001). Respiratory HPIV‐3 viral loads were similar between patients with and without pneumonia. In parallel, HPIV‐3 incidence in the hospital overall was lower than in the hematology unit (p < 0.0001). Air virus screening showed the detection of HPIV‐3 in the air in different areas, and whole‐genome sequencing confirmed the circulation of a single HPIV‐3 strain. Strengthened IPC measures were associated with the containment of the outbreak. HPIV‐3 has high epidemic potential in patients with multiple myeloma and causes severe infections. Our findings highlight the need for routine HPIV‐3 testing in hematology units.

27 May 2026 in Journal of Hospital Infection
Verified
Journal Article
Closed access
STS. Timsit
S. Timsit
CDC. Durand
C. Durand
CBC. Bonnal
C. Bonnal
SHS. Hamane
S. Hamane
AAA. Alanio
A. Alanio
SKS. Kernéis
S. Kernéis

5 August 2026 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
EMEmilie Mallecot
Emilie Mallecot
VBValentine Berti
Valentine Berti
MPMarie Petitjean
Marie Petitjean
JMJulie Meyer
Julie Meyer
SGSignara Gueye
Signara Gueye
LALAURENCE ARMAND-LEFEVRE
LAURENCE ARMAND-LEFEVRE
Cefiderocol (FDC) is a new siderophore-conjugated cephalosporin that enters the periplasm via iron transport systems. However, the specific contribution of individual iron uptake pathways to FDC activity remains unclear. We investigated the role of 13 iron acquisition systems using several Escherichia coli strain collections. FDC MICs were determined in iron-depleted and iron-supplemented media for E. coli mutants (Keio and pathogenic island [PAI]-deleted collections) and for no-acquired β-lactamase or TEM (NoBL/TEM- Ec ) and NDM-producing E. coli (NDM- Ec ) clinical isolates. Prevalence of iron uptake genes was assessed in these isolates, and fec operon prevalence and genomic location were investigated in E. coli genomes from EnteroBase and RefSeq databases. Compared to K-12 and 536 reference E. coli , only Δ cirA and Δ fiu (enterobactin system) showed increased FDC MICs (8- and 3-fold, respectively), while Δ fecA and Δ fecB had lower MICs (3-fold decrease). The fec operon, a known extraintestinal virulence factor, was significantly more prevalent in isolates with FDC MICs above median than below (96% vs. 33% in NoBL/TEM- Ec ; 100% vs. 0% in NDM- Ec ). According to EUCAST breakpoints, 63.6% of fec -positive NDM- Ec were resistant to FDC, whereas none of the fec -negative were. The fec operon was found in 46.5% of E. coli genomes, including virulent clones (ST131, 77%) and was mostly chromosome-borne (99%). Plasmid-borne fec closely resembled that of Enterobacter hormaechei or Klebsiella pneumoniae , suggesting interspecies transfer. Our findings highlight the role of Fec in reducing FDC susceptibility and promoting resistance in NDM-producing E. coli . They challenge the virulence-resistance trade-off demonstrating the “liaisons dangereuses” between iron and antibiotics.